Procyanidins from evening primrose (Oenothera paradoxa) Defatted seeds inhibit invasiveness of breast cancer cells and modulate the expression of selected genes involved in angiogenesis, metastasis, and apoptosis

Nutrition and Cancer

Volumn 65, Issue 8, 2013, Pages 1219-1231

  Lewandowska, Urszula ^a   Szewczyk, Karolina ^a   Owczarek, Katarzyna ^a   Hrabec, Zbigniew ^a   Podsȩdek, Anna ^b   Sosnowska, Dorota ^b   Hrabec, Elzbieta ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIC ACID; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; PROCYANIDIN; PROTEIN BCL 2; PROTEIN C FOS; PROTEIN C JUN; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EVENING PRIMROSE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; INCUBATION TIME; METASTASIS; PLANT SEED; TUMOR INVASION; WESTERN BLOTTING;

OENOTHERA; OENOTHERA PARADOXA;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BIFLAVONOIDS; CATECHIN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHEMOPREVENTION; FEMALE; HUMANS; KI-67 ANTIGEN; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; OENOTHERA; PLANT EXTRACTS; PROANTHOCYANIDINS; PROTO-ONCOGENE PROTEINS C-FOS; RNA, MESSENGER; SEEDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84888338170     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.830314     Document Type: Article

References (50)

1. Liu RH: Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr 78, 517S-520S, 2003.
2. Zessner H, Pan L, Will F, Klimo K, Knauft J, et al.: Fractionation of polyphenol-enriched apple juice extracts to identify constituents with cancer chemopreventive potential. Mol Nutr Food Res 52, 28-44, 2008.
3. de Kok TM, van Breda SG, and Manson MM: Mechanisms of combined action of different chemopreventive dietary compounds: a review. Eur J Nutr 47, 51-59, 2008.
4. Ramos S: Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol Nutr Food Res 52, 507-526, 2008.
5. McCawley LJ, and Matrisian LM: Matrix metalloproteinases: multifunctional contributors to tumor progression. MolMed Today 6, 149-156, 2000.
6. Somerville RPT, Oblander SA, and Apte SS: Matrix metalloproteinases: old dogs with new tricks. Genome Biol 4, 216, 2003.
7. Fingleton B:Matrix metalloproteinases as valid clinical targets. Curr Pharm Des 13, 333-346, 2007.
8. Katiyar SK: Matrix metalloproteinases in cancer metastasis: molecular targets for prostate cancer prevention by green tea polyphenols and grape seed proanthocyanidins. Endocr Metab Immune Disord Drug Targets 6, 17-24, 2006.
9. Cheng XW, Kuzuya M, Kanda S, Maeda K, Sasaki T, et al.: Epigallocatechin-3-gallate binding to MMP-2 inhibits gelatinolytic activity without influencing the attachment to extracellular matrix proteins but enhances MMP-2 binding to TIMP-2. Arch Biochem Biophys 415, 126-132, 2003.
10. Egeblad M, and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 3, 161-174, 2002.
11. Gorlach S, Wagner W, Podsedek A, Sosnowska D, Dastych J, et al.: Polyphenols from evening primrose (Oenothera paradoxa) defatted seeds induce apoptosis in human colon cancer Caco-2 cells. J Agric Food Chem 59, 6985-6997, 2011.
12. Bordonaba JG, and Terry LA: Biochemical profiling and chemometric analysis of seventeen UK-grown black currant cultivars. J Agric Food Chem 56, 6447-6452, 2008.
13. Swain T, and Hillis WE: The phenolics constituents of Prunus domestica II. J Sci Food Agric 10, 63-68, 1959.
14. R̈osch D, Bergmann M, Knorr D, and Kroh LW: Structure: antioxidant efficiency relationships of phenolic compounds and their contribution to the antioxidant activity of sea buckthorn juice. J Agric Food Chem 51, 4233-4239, 2003.
15. Hartzfeld PW, Forkner R, Hunter MD, and Hagerman AE: Determination of hydrolyzable tannins (gallotannins and ellagitannins) after reaction with potassium iodate. J Agric Food Chem 50, 1785-1790, 2002.
16. Kennedy JA, and Jones GP: Analysis of proanthocyanidin cleavage products following acid-catalysis in the presence of excess phloroglucinol. J Agric Food Chem 49, 1740-1746, 2001.
17. Henriksson E, Kjelĺen E, Wahlberg P, Wennerberg J, and Kjellstr̈om JH: Differences in estimates of cisplatin-induced cell kill in vitro between colorimetric and cell count/colony assays. In Vitro Cell Dev Biol Anim 42, 320-323, 2006.
18. Lewandowska U, Szewczyk K, Owczarek K, Hrabec Z, Pods-edek A, et al.: Flavanols from Japanese quince (Chaenomeles japonica) fruit inhibit human prostate and breast cancer cell line invasiveness and cause favorable changes in bax/bcl-2 mRNA ratio. Nutr Cancer 65, 273-285, 2013.
19. Jespersen C, Doller A, Akool S, Bachmann M, M̈uller R, et al.: Molecular mechanisms of nitric oxide-dependent inhibition of TPA-induced matrix metalloproteinase-9 (MMP-9) inMCF-7 cells. J Cell Physiol 219, 276-287, 2009.
20. Hrabec E, Str-ek M, Nowak D, Greger J, Suwalski M, et al.: Activity of type IV collagenases (MMP-2 and MMP-9) in primary pulmonary carcinomas: a quantitative analysis. J Cancer Res Clin Oncol 128, 197-204, 2002.
21. PfafflMW, Horgan GW, and Dempfle L: Relative Expression Software Tool (REST(c)) for group wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30, e36, 2002.
22. Andreotti C, Ravaglia D, and Ragaini A: Phenolic compounds in peach (Prunus persica) cultivars at harvest and during fruit maturation. Ann Appl Bio 153, 11-23, 2008.
23. Chuah AM, Lee YC, Yamaguchi T, Takamura H, Yin LJ, et al.: Effect of cooking on the antioxidant properties of coloured peppers. Food Chem 111, 20-28, 2008.
24. CerdaB, Espin JC, Parra S, Martinez P, and Tomas-Barberan FA: The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans. Eur J Nutr 43, 205-220, 2004.
25. D'Archivio M, FilesiC,VariR, Scazzocchio B, andMasella R: Bioavailability of the polyphenols: status and controversies. IntJMol Sci 11, 1321-1342, 2010.
26. Rios LY, Bennett RN, Lazarus SA, Remesy C, Scalbert A, et al. : Cocoa procyanidins are stable during gastric transit in humans. Am J Clin Nutr 76, 1106-1110, 2002.
27. Scalbert A, and Williamson G: Dietary intake and bioavailability of polyphenols. J Nutr 130, 2073-2085, 2000.
28. Yamakoshi J, Saito M, Kataoka S, and Tokutake S: Procyanidin-rich extract from grape seeds prevents cataract formation in here ditary cataractous (ICR/f) rats. J Agric Food Chem 50, 4983-4988, 2002.
29. Thomasset SC, Berry DP, Garcea G, Marczylo T, Steward WP, et al. : Dietary polyphenolic phytochemicals: promising cancer chemopreventive agents in humans? A review of their clinical properties. Int J Cancer 120, 451-458, 2007.
30. Rocha S, Generalov R, Pereira MC, Peres I, Juzenas P, et al.: Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention. Nanomedicine 6, 79-87, 2011.
31. Landis-Piwowar K, Chen D, Chan TH, and Dou QP: Inhibition of catechol-O-methyltransferase activity in human breast cancer cells enhances the biological effect of the green tea polyphenol (?)-EGCG. Oncol Rep 24, 563-556, 2010.
32. Meeran SM, Patel SN, Chan TH, Trygve O, et al.: A novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT repression in human breast cancer cells. Cancer Prev Res (Phila) 4, 1243-1254, 2011.
33. Li H, Zhao X, Ma Y, Zhai G, Li L, et al.: Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release 133, 238-244, 2009.
34. Musia? W, and Kubis A: Biodegradable polymers for colon-specific drug delivery. Polim Med 35, 51-61, 2005.
35. Zaitone SA, MoustafaYM, Mosaad SM, and El-Orabi NF: Effect of evening primrose oil and ?-3 polyunsaturated fatty acids on the cardiovascular risk of celecoxib in rats. J Cardiovasc Pharmacol 58, 72-79, 2011.
36. Koo JH, Lee I, Yun SK, Kim HU, Park BH, et al.: Saponified evening primrose oil reduces melanogenesis in B16 melanoma cells and reduces UV-induced skin pigmentation in humans. Lipids 45, 401-407, 2010.
37. Arimura T, Kojima-Yuasa A, Suzuki M, Kennedy DO, and Matsui-Yuasa I: Caspase independent apoptosis induced by evening primrose extract in Ehrlich ascites tumor cells. Cancer Lett 201, 9-16, 2003.
38. Kiss AK, Derwínska M, Dawidowska A, and Naruszewicz M: Novel biological properties of Oenothera paradoxa defatted seed extracts: effects on metallopeptidase activity. J Agric Food Chem 56, 7845-7852, 2008.
39. Hoffmann GR: A perspective on the scientific, philosophical, and policy dimensions of hormesis. Dose Response 7, 1-51, 2009.
40. de Kok TM, van Breda SG, and Manson MM: Mechanisms of combined action of different chemopreventive dietary compounds: a review Eur J Nutr 47, 51-59, 2008.
41. Wu LS, Wang XJ, Wang H, Yang HW, Jia AQ, et al.: Cytotoxic polyphenols against breast tumor cell in Smilax china L. J Ethnopharmacol 130, 460-464, 2010.
42. Adams LS, Phung S, Yee N, Seeram NP, Li L, et al.: Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway. Cancer Res 70, 3594-3605, 2010.
43. KessenbrockK, PlaksV, andWerb Z: Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52-67, 2010.
44. Xu J, Rodriguez D, Petitclerc E, Kim JJ, Hangai M, et al.: Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol 154, 1069-1079, 2001.
45. Thangapazham RL, Passi N, and Maheshwari RK: Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells. Cancer Biol Ther 6, 1938-1943, 2007.
46. Zhang X, Fang H, Zhang J, Yuan Y, Xu W, et al.: Recent advance in aminopeptidase N(APN/CD13) inhibitor research. Curr Med Chem 18, 5011-5021, 2011.
47. Bond M, Fabunmi RP, Baker AH, and Newby AC: Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett 43, 29-34, 1998.
48. Lamoreaux WJ, Fitzgerald ME, Reiner A, Hasty KA, and Charles ST: Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvasc Res 55, 29-42, 1998.
49. Viale G, Regan MM, Mastropasqua MG, Maffini F, Maiorano E, et al.: Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. J Natl Cancer Inst 100, 207-212, 2008.
50. Raisova M, Hossini AM, Eberle J, Riebeling C, Wieder T, et al.: The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. J Invest Dermatol 117, 333-340, 2001.